TITLE

[-215G>A; IVS3+2T>C] mutation in the SPINK1 gene causes exon 3 skipping and loss of the trypsin binding site

AUTHOR(S)
Kume, K.; Masamune, A.; Kikuta, K.; Shimosegawa, T.
PUB. DATE
August 2006
SOURCE
Gut;Aug2006, Vol. 55 Issue 8, p1214
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented related to the mutations in the serine protease inhibitor Kazal type 1gene, and its related disorders.
ACCESSION #
21843708

 

Related Articles

  • NT5E Mutations and Arterial Calcifications. Riksen, Niels P.; Rongen, Gerard A. // New England Journal of Medicine;4/21/2011, Vol. 364 Issue 16, p1577 

    A letter to the editor is presented in response to an article on NT5E gene mutations submitted by St. Hilaire et al.

  • Gene-Expression Profiles in Hereditary Breast Cancer. Olopade, Olufunmilayo I.; Grushko, Tatyana // New England Journal of Medicine;06/28/2001, Vol. 344 Issue 26, p2028 

    A letter to the editor is presented in response to the article "Gene-Expression Profiles in Hereditary Breast Cancer," by I. Hedenfalk and associates in the February 22, 2007 issue.

  • Gene-Expression Profiles in Hereditary Breast Cancer. Sudbø, Jon; Reith, Albrecht; Lingjærde, Ole Christian // New England Journal of Medicine;06/28/2001, Vol. 344 Issue 26, p2028 

    A letter to the editor is presented in response to the article "Gene-Expression Profiles in Hereditary Breast Cancer," by I. Hedenfalk and associates in the February 22, 2007 issue.

  • Gene-Expression Profiles in Hereditary Breast Cancer. Hedenfalk, Ingrid; Simon, Richard; Trent, Jeffrey // New England Journal of Medicine;06/28/2001, Vol. 344 Issue 26, p2028 

    A letter to the editor is presented in response to the article "Gene-Expression Profiles in Hereditary Breast Cancer," by I. Hedenfalk and associates in the February 22, 2007 issue.

  • Gene Therapy for Severe Combined Immunodeficiency Disease. Handgretinger, Rupert; Koscielniak, Ewa; Niethammer, Dietrich // New England Journal of Medicine;8/22/2002, Vol. 347 Issue 8, p613 

    A letter to the editor is presented in response to an article by Salima Hacein-Bey-Abina and colleagues about gene therapy for severe combined immunodeficiency disease in the April 18, 2002 issue.

  • Gene Therapy for Severe Combined Immunodeficiency Disease. Cavazzana-Calvo, Marina; Hacein-Bey-Abina, Salima; Fischer, Alain // New England Journal of Medicine;8/22/2002, Vol. 347 Issue 8, p613 

    A response by Salima Hacein-Bey-Abina and colleagues to a letter to the editor about their article concerning gene therapy for severe combined immunodeficiency disease, which appeared in the April 18, 2002 issue, is presented.

  • AILUN: reannotating gene expression data automatically. Rong Chen; Li Li; Butte, Atul J. // Nature Methods;Nov2007, Vol. 4 Issue 11, p879 

    A letter to the editor regarding gene expression data is presented.

  • Reannotation of array probes at NCBI's GEO database. Barrett, Tanya; Edgar, Ron // Nature Methods;Feb2008, Vol. 5 Issue 2, p117 

    A letter to the editor is presented about Gene Expression Omnibus database.

  • Molecular Mechanism of a Frequent Genetic Form of Deafness. Michel, Vincent; Hardelin, Jean-Pierre; Petit, Christine // New England Journal of Medicine;8/14/2003, Vol. 349 Issue 7, p716 

    A letter to the editor about the genes encoding the major conexins of the cochlea is presented.

  • Immune Signatures in Follicular Lymphoma. Tibshirani, Robert // New England Journal of Medicine;4/7/2005, Vol. 352 Issue 14, p1496 

    A letter to the editor is presented in response to a study on correlating gene expression with survival in follicular lymphoma by researcher Sandeep Dave and associates in the November 18, 2004 issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics